Published in Healthcare Mergers, Acquisitions and Ventures Week, October 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at ImClone Systems Incorporated.
Report 1: ImClone Systems Incorporated (NASDAQ: IMCL), a leader in the development and commercialization of novel cancer therapeutics, announced that it has appointed John H. Johnson as its Chief Executive Officer, effective August 27, 2007.
Mr. Johnson, age 49, has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. He has held senior management positions of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week